HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inorganic nanovehicle targets tumor in an orthotopic breast cancer model.

Abstract
The clinical efficacy of conventional chemotherapeutic agent, methotrexate (MTX), can be limited by its very short plasma half-life, the drug resistance, and the high dosage required for cancer cell suppression. In this study, a new drug delivery system is proposed to overcome such limitations. To realize such a system, MTX was intercalated into layered double hydroxides (LDHs), inorganic drug delivery vehicle, through a co-precipitation route to produce a MTX-LDH nanohybrid with an average particle size of approximately 130 nm. Biodistribution studies in mice bearing orthotopic human breast tumors revealed that the tumor-to-liver ratio of MTX in the MTX-LDH-treated-group was 6-fold higher than that of MTX-treated-one after drug treatment for 2 hr. Moreover, MTX-LDH exhibited superior targeting effect resulting in high antitumor efficacy inducing a 74.3% reduction in tumor volume compared to MTX alone, and as a consequence, significant survival benefits. Annexin-V and propidium iodine dual staining and TUNEL analysis showed that MTX-LDH induced a greater degree of apoptosis than free MTX. Taken together, our data demonstrate that a new MTX-LDH nanohybrid exhibits a superior efficacy profile and improved distribution compared to MTX alone and has the potential to enhance therapeutic efficacy via inhibition of tumor proliferation and induction of apoptosis.
AuthorsGoeun Choi, Oh-Joon Kwon, Yeonji Oh, Chae-Ok Yun, Jin-Ho Choy
JournalScientific reports (Sci Rep) Vol. 4 Pg. 4430 (Mar 21 2014) ISSN: 2045-2322 [Electronic] England
PMID24651154 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aluminum Silicates
  • Annexin A5
  • Antimetabolites, Antineoplastic
  • Drug Carriers
  • Propidium
  • Magnesium Hydroxide
  • Methotrexate
Topics
  • Aluminum Silicates (chemistry)
  • Animals
  • Annexin A5
  • Antimetabolites, Antineoplastic (chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Breast Neoplasms (drug therapy, pathology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Drug Carriers
  • Drug Compounding
  • Female
  • Half-Life
  • Heterografts
  • Humans
  • Liver (drug effects)
  • Magnesium Hydroxide (chemistry)
  • Mammary Glands, Animal (drug effects, pathology)
  • Methotrexate (chemistry, pharmacology)
  • Mice
  • Neoplasm Transplantation
  • Particle Size
  • Propidium
  • Tumor Burden (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: